SCHOTT and Xinkang agree on joint venture in China

This week, German technology group SCHOTT and the Chinese company Zhejiang Xinkang Pharmaceutical Glass Co., Ltd. signed an agreement to establish a pharmaceutical packaging joint venture in China. SCHOTT will own the majority of shares of the new company that will supply the fast-growing Chinese pharmaceutical market with high-quality pharmaceutical packaging products made of glass. The closing of the joint venture is subject to customary closing conditions.

“With the formation of this joint venture between SCHOTT and Xinkang, two strong partners are joining forces. By combining Xinkang’s knowledge of the local market with SCHOTT’s technological expertise, we will be able to supply Chinese pharmaceutical companies with high-quality packaging products even more effectively in the future,” explained Prof. Udo Ungeheuer, Chairman of the Board of Management of SCHOTT AG.

With this joint venture, SCHOTT will be strengthening its position in the important growth market of China and continuing its expansion in the emerging pharmaceutical markets. SCHOTT Pharmaceutical Systems already operates manufacturing facilities in countries like Brazil, Russia and India. The joint enterprise will manufacture at both SCHOTT’s existing site in Suzhou, Jiangsu Province and in Jinyun, Zhejiang Province.

18.11.2011, SCHOTT/schott.com

News material on the Site is copyright and belongs to the Company or to its third party news provider, and all rights are reserved. Any User who accesses such material may do so only for its own personal use, and the use of such material is at the sole risk of the User. Redistribution or other commercial exploitation of such news material is expressly prohibited. Where such news material is provided by a third party, each User agrees to observe and be bound by the specific terms of use applying to such news material. We do not represent or endorse the accuracy or reliability of any of the info contained in any news or external websites referred to in the news.

Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.